Vizsgálati helyszín
Vitamed Galaj i Cichomski sp.j.
Bydgoszcz, Kuyavian-Pomeranian Voivodeship 85-079, LengyelországEU-13 felzárkózó országMég nincs intézményhez kötve
- 19futó vizsgálat
- 22lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 42 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis22 vizsgálat
- 2. fázis17 vizsgálat
- 1/2. fázis1 vizsgálat
- 2/3. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult21 vizsgálat
- Fut, nem toboroz11 vizsgálat
- Toboroz5 vizsgálat
- Még nem toboroz3 vizsgálat
- Felfüggesztve1 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Hoffmann-La Roche8 vizsgálat
- AbbVie5 vizsgálat
- Avalyn Pharma Inc.2 vizsgálat
- Bristol-Myers Squibb Services Unlimited Company2 vizsgálat
- Chiesi Farmaceutici S.p.A.2 vizsgálat
- és még 23
Futó vizsgálatok
Még nem toboroz
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás
Még nem toboroz
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás
Toboroz
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
NCT07513181· 2. fázis· Athos Therapeutics Inc· Forrás
Toboroz
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
NCT07230288· 2. fázis· AbbVie· Forrás
Toboroz
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
NCT07284459· 2. fázis· Contineum Therapeutics· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
2024-512914-16-00· 3. fázis· Amgen Inc.· Forrás
Toboroz
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled
Antifibrotic Agent
2024-518289-28-00· 2. fázis· Avalyn Pharma Inc.· Forrás
Fut, nem toboroz
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis
2023-509069-19-00· 2. fázis· Vicore Pharma AB· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
2023-503699-25-00· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
2023-503697-21-01· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Toboroz
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
NCT06094010· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT05269004· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
NCT04777331· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586023· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
NCT04639050· 1/2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
NCT03398135· 3. fázis· AbbVie· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis.
2023-507705-34-00· 3. fázis· Alvotech Swiss AG· Forrás
Lezárult
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás
Lezárult
A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain
NCT06379893· 4. fázis· HALEON· Forrás
Lezárult
Efficacy and Safety of ANB032 in the Treatment of Subjects with Atopic Dermatitis
2023-503522-40-01· 2. fázis· Anaptysbio Inc.· Forrás
Fut, nem toboroz
A study to evaluate the safety and long-term biomarker effects of RO7269162 in participants at risk for or at the prodromal stage of Alzheimer’s Disease (AD)
2023-506183-13-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás
Lezárult
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
NCT06241313· 3. fázis· AbbVie· Forrás
Lezárult
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
NCT06132256· 2. fázis· Syndax Pharmaceuticals· Forrás
Lezárult
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis
2022-503005-38-00· 2. fázis· Landos Biopharma Inc.· Forrás
Lezárult
Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).
NCT06264674· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás
Lezárult
Efficacy and safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund maintenance therapy
2022-502208-64-00· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás
Lezárult
A study in people with moderately to severely active ulcerative colitis to see how well an investigational treatment called PB016 works and how safe it is compared to a licensed treatment called Entyvio®.
2022-502778-18-00· 3. fázis· Polpharma Biologics S.A.· Forrás
Leállították
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás
Lezárult
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine
NCT05748483· 3. fázis· AbbVie· Forrás
Lezárult
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
NCT05483907· 2. fázis· Bridge Biotherapeutics, Inc.· Forrás
Lezárult
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
NCT05595642· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
NCT04991935· 3. fázis· Celgene· Forrás
Lezárult
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis
2024-515964-30-00· 2. fázis· Avalyn Pharma Inc.· Forrás
Lezárult
A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion in Pediatric Subjects with Moderate to Severe Plaque Psoriasis
2024-520057-20-00· 2. fázis· Bausch Health Americas Inc.· Forrás
Lezárult
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine
NCT04686136· 3. fázis· AbbVie· Forrás
Lezárult
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
NCT04609878· 3. fázis· AstraZeneca· Forrás
Lezárult
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
NCT04469686· 3. fázis· Cristcot HCA LLC· Forrás
Lezárult
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
NCT03283085· 3. fázis· Shire· Forrás
Hibát jelzek